Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Inovio Pharmaceuticals, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$0.79 - $1.91 $7,288 - $17,621	9,226 Added 7.82%	127,226 $104,000
Q4 2022 Feb 07, 2023	SELL	$1.41 - $2.5 $14,169 - $25,122	-10,049 Reduced 7.85%	118,000 $184,000
Q3 2022 Nov 01, 2022	BUY	$1.66 - $2.79 $2,571 - $4,321	1,549 Added 1.22%	128,049 $221,000
Q2 2022 Aug 04, 2022	BUY	$1.44 - $3.98 $117,583 - $324,986	81,655 Added 182.08%	126,500 $219,000
Q1 2022 May 09, 2022	BUY	$2.97 - $5.2 $14,544 - $25,464	4,897 Added 12.26%	44,845 $161,000
Q4 2021 Feb 07, 2022	SELL	$4.99 - $7.46 $25,543 - $38,187	-5,119 Reduced 11.36%	39,948 $208,000
Q2 2021 Aug 06, 2021	BUY	$6.23 - $10.03 $80,952 - $130,329	12,994 Added 40.51%	45,067 $418,000
Q1 2021 May 06, 2021	BUY	$8.81 - $16.96 $89,456 - $172,211	10,154 Added 46.33%	32,073 $298,000
Q4 2020 Feb 09, 2021	BUY	$8.5 - $12.85 $73,295 - $110,805	8,623 Added 64.85%	21,919 $194,000
Q3 2020 Nov 10, 2020	BUY	$9.57 - $27.05 $1,349 - $3,814	141 Added 1.07%	13,296 $154,000
Q2 2020 Aug 06, 2020	BUY	$7.14 - $31.69 $93,926 - $416,881	13,155 New	13,155 $355,000
Q4 2019 Feb 05, 2020	SELL	$1.97 - $3.72 $79,741 - $150,578	-40,478 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.05 - $3.02 $10,834 - $15,960	5,285 Added 15.02%	40,478 $83,000
Q2 2019 Aug 08, 2019	BUY	$2.29 - $4.1 $8,424 - $15,083	3,679 Added 11.67%	35,193 $103,000
Q1 2019 Apr 26, 2019	BUY	$3.34 - $5.1 $8,941 - $13,652	2,677 Added 9.28%	31,514 $118,000
Q4 2018 Feb 08, 2019	BUY	$3.89 - $6.11 $8,686 - $13,643	2,233 Added 8.39%	28,837 $123,000
Q3 2018 Nov 13, 2018	BUY	$3.92 - $5.58 $104,287 - $148,450	26,604 New	26,604 $148,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $566M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account